[go: up one dir, main page]

AU2001228863A1 - Remedies for ophthalmic diseases - Google Patents

Remedies for ophthalmic diseases

Info

Publication number
AU2001228863A1
AU2001228863A1 AU2001228863A AU2886301A AU2001228863A1 AU 2001228863 A1 AU2001228863 A1 AU 2001228863A1 AU 2001228863 A AU2001228863 A AU 2001228863A AU 2886301 A AU2886301 A AU 2886301A AU 2001228863 A1 AU2001228863 A1 AU 2001228863A1
Authority
AU
Australia
Prior art keywords
remedies
ophthalmic diseases
ophthalmic
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001228863A
Inventor
Hideaki Hara
Nobuaki Miyawaki
Hidenobu Tanihara
Shinji Yoneda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of AU2001228863A1 publication Critical patent/AU2001228863A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/245—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001228863A 2000-01-31 2001-01-30 Remedies for ophthalmic diseases Abandoned AU2001228863A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-21446 2000-01-31
JP2000021446 2000-01-31
JP2000-268829 2000-09-05
JP2000268829 2000-09-05
PCT/JP2001/000617 WO2001056606A1 (en) 2000-01-31 2001-01-30 Remedies for ophthalmic diseases

Publications (1)

Publication Number Publication Date
AU2001228863A1 true AU2001228863A1 (en) 2001-08-14

Family

ID=26584457

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001228863A Abandoned AU2001228863A1 (en) 2000-01-31 2001-01-30 Remedies for ophthalmic diseases

Country Status (4)

Country Link
EP (1) EP1252895A4 (en)
AU (1) AU2001228863A1 (en)
CA (1) CA2398900A1 (en)
WO (1) WO2001056606A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2602573C (en) 2005-03-31 2013-10-08 Asahi Glass Co Ltd Protective agent for retinal neuronal cell containing prostaglandin f2 .alpha. derivative as active ingredient
US8252945B2 (en) 2005-04-13 2012-08-28 Ube Industries, Ltd. Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
US20120014970A1 (en) * 2009-01-09 2012-01-19 Reza Dana Therapeutic Compositions for Treatment of Corneal Disorders
JP2012515164A (en) 2009-01-09 2012-07-05 ザ スキーペンズ アイ リサーチ インスティチュート インコーポレイテッド Therapeutic composition for treating corneal disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868154A (en) * 1986-02-19 1989-09-19 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with melanocyte stimulating hormones
SE8701258D0 (en) * 1987-03-26 1987-03-26 Pharmacia Ab A COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION
WO1991003245A1 (en) * 1989-08-28 1991-03-21 Alcon Laboratories, Inc. Ophthalmic composition
JPH05320072A (en) * 1992-05-20 1993-12-03 Taiho Yakuhin Kogyo Kk Drug for ischemic brain disease
JPH08502033A (en) * 1992-07-08 1996-03-05 セルトリックス ファーマシューティカルズ，インコーポレイテッド Method for treating eye disease using TGF-β
US5922773A (en) * 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
AU3584895A (en) * 1994-09-28 1996-04-19 Celtrix Pharmaceuticals, Inc. Method of treating macular degeneration using tgf-beta
SG80568A1 (en) * 1996-03-05 2001-05-22 Johnson & Johnson Vision Prod Contact lens containing a leachable absorbed antibody
AU2438297A (en) * 1996-05-09 1997-11-26 Alcon Laboratories, Inc. Combinations of angiostatic compounds
GB9621129D0 (en) * 1996-10-10 1996-11-27 Duff Gordon W Detecting genetic predisposition to sight-threatening diabetic retinopathy
WO1998022130A1 (en) * 1996-11-19 1998-05-28 The Schepens Eye Research Institute, Inc. Local use of il-1ra in corneal transplant rejection or disorders of the eye
IT1295423B1 (en) * 1997-10-10 1999-05-12 Medivis S R L USE OF FLUNARIZINE IN TOPICAL GLAUCOMA THERAPY
GB9723835D0 (en) * 1997-11-13 1998-01-07 Nicklin Martin Interleukin knockout
CA2395417A1 (en) * 1999-12-10 2001-06-14 Amgen Inc. Interleukin-1 receptor antagonist-related molecules and uses thereof

Also Published As

Publication number Publication date
WO2001056606A1 (en) 2001-08-09
EP1252895A1 (en) 2002-10-30
CA2398900A1 (en) 2001-08-09
EP1252895A4 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
AU2001227837A1 (en) Novel treatment for eye disease
AU2001286221A1 (en) Remedies for ischemic diseases
AU2001244188A1 (en) Medicaments against viral diseases
AU2001246876A1 (en) Remedies
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AU2001246877A1 (en) Remedies
HUP0200994A3 (en) Remedies for immunological diseases
AU2002212695A1 (en) Remedies for arachidonic acid-induced skin diseases
AU2002305578A1 (en) Applanation tonometer
AU2002343739A1 (en) Improved therapy for topical diseases
AU2000265525A1 (en) Medicament for treating intestinal diseases
AU2000279614A1 (en) Remedies for endothelin-induced diseases
AU2001241162A1 (en) Remedies for allergic diseases
AU2001236006A1 (en) Preventives/remedies for kidney diseases
AU2002315848A1 (en) Remedies for eosinophilic diseases
IL159478A0 (en) Remedies for eosinophilic diseases
MXPA01003761A (en) Remedies for ocular diseases.
AU2002212234A1 (en) Stable ophthalmic preparation
AU2003272962A1 (en) Remedies for allergic diseases
AU2001228863A1 (en) Remedies for ophthalmic diseases
AU2001271026A1 (en) Remedies for bone diseases
AU7320200A (en) P21cip1 remedies for rheumatism
AU2003227191A1 (en) Remedies for protozoan diseases
AU2001229209A1 (en) Hydrokeratome for refractive surgery
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases